Genialis

Genialis develops end-to-end bioinformatics software solutions combining biomedical data management, customizable data analysis pipelines, and interactive visualizations. The platform provides a complete data ecosystem for sequencing data management, analysis, visualization, and dissemination. Founded in 2015 and headquartered in Boston, United States, Genialis has raised $16M in Series A funding from investors including Redalpine, First Star Ventures, Debiopharm, EIC Fund, and ScaleX. The company offers cloud-based and on-premise software that automates data management and analysis tasks for genomics research, serving pharmaceutical companies, academic institutions, and clinical research organizations with tools for RNA-seq analysis, biomarker discovery, and translational research. The company employs 30 people and its platform accelerates the translation of genomic discoveries into clinical applications by streamlining complex bioinformatics workflows.

Life Sciences Tech > Research & Development > Drug Discovery > Cheminformatics